TERT and astrocytoma (excluding glioblastoma): In the present study, we excluded patients with oligodendroglioma, or those with IDH mutated- TERT promoter mutated, or both because oligodendroglioma is considered to show better prognosis than astrocytoma and is often accompanied by both IDH and TERT promoter mutations.